ALLMedicine™ Strongyloidiasis Center
Research & Reviews 341 results
Diagnostic Microbiology and Infectious Disease; Gonzaga HT, Mendonça SCL et. al.
Mar 27th, 2023 - We report the detection of IgG, IgG1, IgG4 and IgE anti-Strongyloides stercoralis as complementary tool for screening in patients with diabetes in hyperendemic areas for strongyloidiasis. A panel of 119 serum samples were analyzed: 76 from patient...
The American Journal of Tropical Medicine and Hygiene; Tanariyakul M, Chang B et. al.
Mar 21st, 2023 - The clinical impact of Strongyloides stercoralis hyperinfection secondary to immunosuppressive therapy for coronavirus disease 2019 (COVID-19) has been an emerging topic of interest, although characteristics of Strongyloides infection in COVID-19 ...
International Journal for Parasitology. Parasites and Wil... Richins T, Sapp SGH et. al.
Mar 3rd, 2023 - Human strongyloidiasis is an important neglected tropical disease primarily caused by the nematode Strongyloides stercoralis, and to a lesser extent Strongyloides fuelleborni which mainly infects non-human primates. Zoonotic sources of infection h...
BMC Nephrology; Tebib N, Tebib N et. al.
Feb 9th, 2023 - Strongyloidiasis is an infectious disease that can be fatal in immunocompromised patients. Patients with end-stage renal failure who are on dialysis have a considerably weakened immune system, and organ transplantation is a major risk factor for s...
Transplantation Bansal SB, Ramasubramanian V et. al.
Feb 8th, 2023 - These guidelines discuss the epidemiology, screening, diagnosis, posttransplant prophylaxis, monitoring, and management of endemic infections in solid organ transplant (SOT) candidates, recipients, and donors in South Asia. The guidelines also pro...
Drugs 5 results see all →
Clinicaltrials.gov 6 results
Nov 3rd, 2022 - Aim and objectives The aim of this project is to provide fundamental information on the performance and applicability of diagnostic methods for the assessment of S. stercoralis infection to inform the forthcoming WHO global strongyloidiasis contro...
May 21st, 2021 - In late 2019, an unidentified viral pneumonia was detected in Wuhan, China. Later, it was declared that it was pneumonia due to a new coronavirus. The World Health Organization (WHO) officially called it COVID-19 disease (Xie and Chen 2020). Iverm...
Jan 14th, 2021 - Strongyloidiasis is a worm infection which affects more than 100 million people, mostly in Africa, Asia and Latin America. Infection can persist for decades, and usually causes mild symptoms. In some people with reduced immune systems (for example...
Jun 14th, 2018 - Ivermectin is currently the best drug to cure strongyloidiasis, but the "standard" single dose of 200 mcg/kg is probably not enough to guarantee cure. As strongyloidiasis can be fatal in immunosuppressed patients, it is mandatory to define the opt...
Sep 7th, 2017 - A prospective controlled trial to compare the efficacy and safety of 7-day albendazole, single dose ivermectin, and 2-single dose ivermectin in 72 patients with chronic strongyloidiasis will be conducted at Siriraj Hospital, Bangkok, Thailand.
News 15 results
Mar 22nd, 2022 - This transcript has been edited for clarity. Welcome to Impact Factor, your weekly dose of commentary on a new medical study. I'm Dr F. Perry Wilson of the Yale School of Medicine If you took a random sample of 100 people from around the world, ei...
Mar 22nd, 2022 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The anti-parasitic drug ivermectin does not reduce hospitalizations of people infected with COVID-19, according to a large study conducted in Cana...
Mar 8th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The US Food and Drug Administration (FDA) has issued guidance warning consumers against using the antiparasitic drug ivermectin to treat or preven...
Angie Y. Wan, BA, Melissa Piliang, MD
Jun 9th, 2020 - The Diagnosis: Disseminated Strongyloidiasis Strongyloidiasis is a parasitic infection caused by Strongyloides stercoralis. In the United States it is most prevalent in the Appalachian region.
May 9th, 2017 - SYDNEY – Think twice before prescribing oral steroids for patients who have urticarial dermatitis, diarrhea, and cough, especially if they have lived in or recently traveled to tropical areas, Ian McCrossin, MD, said at the annual meeting of the A.